401 related articles for article (PubMed ID: 20673884)
1. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
2. Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon.
Jaehn PS; Zaenker KS; Schmitz J; Dzionek A
Eur J Immunol; 2008 Jul; 38(7):1822-32. PubMed ID: 18581320
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
[TBL] [Abstract][Full Text] [Related]
4. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
5. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
[TBL] [Abstract][Full Text] [Related]
6. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
7. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
9. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
10. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.
Tel J; Lambeck AJ; Cruz LJ; Tacken PJ; de Vries IJ; Figdor CG
J Immunol; 2010 Apr; 184(8):4276-83. PubMed ID: 20304825
[TBL] [Abstract][Full Text] [Related]
11. Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.
Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
J Immunol Methods; 2010 Oct; 362(1-2):168-75. PubMed ID: 20888334
[TBL] [Abstract][Full Text] [Related]
12. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells.
Flores M; Desai DD; Downie M; Liang B; Reilly MP; McKenzie SE; Clynes R
J Immunol; 2009 Dec; 183(11):7129-39. PubMed ID: 19917701
[TBL] [Abstract][Full Text] [Related]
13. Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Hsieh CC; Kuo HF; Huang MY; Yang SN; Chen LC; Huang SK; Hung CH
Allergy; 2013 Jul; 68(7):870-9. PubMed ID: 23738920
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.
Lund J; Sato A; Akira S; Medzhitov R; Iwasaki A
J Exp Med; 2003 Aug; 198(3):513-20. PubMed ID: 12900525
[TBL] [Abstract][Full Text] [Related]
15. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
Schroeder JT; Chichester KL; Bieneman AP
J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
[TBL] [Abstract][Full Text] [Related]
17. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
[TBL] [Abstract][Full Text] [Related]
18. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
[TBL] [Abstract][Full Text] [Related]
19. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling.
Bos S; Poirier-Beaudouin B; Seffer V; Manich M; Mardi C; Desprès P; Gadea G; Gougeon ML
Front Immunol; 2020; 11():582061. PubMed ID: 33193389
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Kaushik S; Teque F; Patel M; Fujimura SH; Schmidt B; Levy JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):501-10. PubMed ID: 23131038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
